Literature DB >> 23103497

Chronic hypoxia decreases arterial and venous compliance in isolated perfused rat lungs: an effect that is reversed by exogenous L-arginine.

Yi Jin1, Bernadette Chen, Thomas J Calvert, Louis G Chicoine, Yusen Liu, Leif D Nelin.   

Abstract

Chronic hypoxia (CH)-induced pulmonary hypertension is characterized by vasoconstriction and vascular remodeling, leading to right ventricular dysfunction. Given the role of arterial compliance (C(a)) in right ventricular work, a decrease in C(a) would add to right ventricular work. Nitric oxide (NO) is a potent vasodilator made by NO synthases from L-arginine (L-Arg). However, little is known of the effect of L-Arg on vascular compliance (C(v)) in the lung. We hypothesized that exposure to CH would decrease C(a) and that this effect would be reversed by exogenous L-Arg. Sprague-Dawley rats were exposed to either normoxia or CH for 14 days; the lungs were then isolated and perfused. Vascular occlusions were performed and modeled using a three-compliance, two-resistor model. Pressure-flow curves were generated, and a distensible vessel model was used to estimate distensibility and a vascular resistance parameter (R(0)). Hypoxia resulted in the expected increase in arterial resistance (R(a)) as well as a decrease in both C(a) and C(v). L-Arg had little effect on R(a), C(a), or C(v) in isolated lungs from normoxic animals. L-Arg decreased R(a) in lungs from CH rats and redistributed compliance to approximately that found in normoxic lungs. CH increased R(0), and L-Arg reversed this increase in R(0). L-Arg increased exhaled NO, and inhibition of L-Arg uptake attenuated the L-Arg-induced increase in exhaled NO. These data demonstrate that the CH-induced decrease in C(a) was reversed by L-Arg, suggesting that L-Arg may improve CH-induced right ventricular dysfunction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23103497      PMCID: PMC3543668          DOI: 10.1152/ajpheart.00188.2012

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  42 in total

1.  Systemic lobar shunting induces advanced pulmonary vasculopathy.

Authors:  M Bousamra; R Rossi; E Jacobs; M Parviz; C Busch; L D Nelin; S Haworth; C A Dawson
Journal:  J Thorac Cardiovasc Surg       Date:  2000-07       Impact factor: 5.209

2.  Effects of chronic hypoxia and altered hemodynamics on endothelial nitric oxide synthase expression in the adult rat lung.

Authors:  T D Le Cras; R C Tyler; M P Horan; K G Morris; R M Tuder; I F McMurtry; R A Johns; S H Abman
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

3.  Hypoxia inhibits increased ETB receptor-mediated NO synthesis in hypertensive rat lungs.

Authors:  K Sato; D M Rodman; I F McMurtry
Journal:  Am J Physiol       Date:  1999-04

4.  Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats.

Authors:  Y Mitani; K Maruyama; M Sakurai
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

Review 5.  Distensibility of the normal human lung circulation during exercise.

Authors:  John T Reeves; John H Linehan; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-03       Impact factor: 5.464

6.  Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3.

Authors:  W Steudel; M Scherrer-Crosbie; K D Bloch; J Weimann; P L Huang; R C Jones; M H Picard; W M Zapol
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

7.  Maintained upregulation of pulmonary eNOS gene and protein expression during recovery from chronic hypoxia.

Authors:  T C Resta; L G Chicoine; J L Omdahl; B R Walker
Journal:  Am J Physiol       Date:  1999-02

8.  L-arginine reduces right heart hypertrophy in hypoxia-induced pulmonary hypertension.

Authors:  J M Fagan; S E Rex; S A Hayes-Licitra; L Waxman
Journal:  Biochem Biophys Res Commun       Date:  1999-01-08       Impact factor: 3.575

9.  Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension.

Authors:  Weiling Xu; F Takao Kaneko; Shuo Zheng; Suzy A A Comhair; Allison J Janocha; Tannishia Goggans; Frederik B J M Thunnissen; Carol Farver; Stanley L Hazen; Constance Jennings; Raed A Dweik; Alejandro C Arroliga; Serpil C Erzurum
Journal:  FASEB J       Date:  2004-09-13       Impact factor: 5.191

10.  The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia.

Authors:  K A Fagan; B W Fouty; R C Tyler; K G Morris; L K Hepler; K Sato; T D LeCras; S H Abman; H D Weinberger; P L Huang; I F McMurtry; D M Rodman
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

View more
  2 in total

1.  Deficiency of cationic amino acid transporter-2 protects mice from hyperoxia-induced lung injury.

Authors:  Yi Jin; Yusen Liu; Leif D Nelin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-01-10       Impact factor: 5.464

Review 2.  Therapeutic Potential of Citrulline as an Arginine Supplement: A Clinical Pharmacology Review.

Authors:  Jahidur Rashid; Shaun S Kumar; Kathleen M Job; Xiaoxi Liu; Candice D Fike; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2020-06       Impact factor: 3.022

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.